Evolon Technology, LLC – Trademark Portfolio
Entity Type: 16
Evolon Technology, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ASM, EVOLON, EVOLON EDGE, EVOLON VERIFY, and EVOLON ENTERPRISE. The owner is based in Dallas, TX.
Suite 600
15770 Dallas Pkwy
Dallas, TX 75248
Showing of trademarks Trademarks
Trademark Classifications
Evolon Technology, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Evolon Technology, LLC have?
Evolon Technology, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned, 1 cancelled.
What trademark classes does Evolon Technology, LLC file in?
Evolon Technology, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Evolon Technology, LLC's most well-known trademarks?
Evolon Technology, LLC's registered trademark portfolio includes well-known marks such as ASM, EVOLON, EVOLON EDGE, EVOLON VERIFY, and EVOLON ENTERPRISE. These are among 7 currently registered trademarks in the portfolio.
What is Evolon Technology, LLC's trademark registration success rate?
Evolon Technology, LLC has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.